IEX-1在宫颈癌中的表达及其与HPV感染的相关性
[Abstract]:BACKGROUND AND OBJECTIVE Cervical cancer is one of the most common malignant tumors in the female reproductive system. The incidence of cervical cancer is the third in female cancers worldwide, next only to lung cancer and gastric cancer. About 90% of cervical cancer deaths occur in developing countries, which seriously threaten women's life and health. Squamous cell carcinoma (SCC) and adenocarcinoma (ADCA), cervical squamous cell carcinoma (SCC) account for about 80%, the incidence of cervical adenocarcinoma in recent years is increasing. Persistent high-risk human papilloma virus (HR-HPV) infection is the most important carcinogen of cervical cancer, HPV16 and HPV18 are the most common HR-HPV. Type. E6 and E7 are the major cancer proteins of HR-HPV. E6 can hydrolyze P53 by ubiquitination, leading to loss of apoptosis and/or senescence in P53-dependent cells. E7 binding to P RB leads to cell cycle disorders. Therefore, HR-HPV infection can lead to malignant transformation and tumor development. Charles et al. found in mouse fibroblasts in 1993 Immediate early response gene X-1 (IEX-1), as a member of immediate early gene (IEG), can be expressed briefly and rapidly under a variety of stimulation conditions. These stimulating factors include growth factors, cytokines, ionizing radiation, virus infection and other types of cell stress factors. IEX-1 plays a complex role in regulating cell cycle and apoptosis. Although the expression of IEX-1 has been proved to be out of balance in many human malignant tumors, there is little research on IEX-1 in cervical cancer and IEX-1 in cervical cancer. The expression of IEX-1 in cervical cancer, cervical intraepithelial neoplasia (CIN) and normal cervical tissues was analyzed by immunohistochemistry. The relationship between IEX-1 expression and clinical pathology of cervical cancer was analyzed. To determine the role of IEX-1 in the development of cervical cancer, real-time fluorescence quantitative PRC (RT-q PCR) and Western Blot were used to analyze the expression of IEX-1 in cervical cancer cells with different HPV infection status. Homologous m RNA degrades efficiently and specifically. RNAi method has high sequence specificity. Specific gene silencing can be achieved by transient transfection of Si RNA into cells. Material and Methods 1. Human cervical cancer cell lines Si Ha (HPV16 +), He La (HPV18 +), C-33a (HPV -) were given by Huazhong University of Science and Technology. From January 2010 to October 2014, 132 cervical specimens (124 surgical specimens and 8 biopsy specimens) were collected from the Department of Pathology, First Affiliated Hospital of Zhengzhou University. Among them, 29 cases were normal cervix, aged 32-61 years; 46 cases of CIN (19 cases of grade I, 17 cases of grade II, 10 cases of grade III), aged 29-58 years; 57 cases of cervical cancer (35 cases of squamous cell carcinoma, 22 cases of adenocarcinoma), aged 27-65 years. According to FIGO clinical staging, 23 cases of cervical cancer were stage I, 26 cases of stage II, 6 cases of stage III and 2 cases of stage IV. Differentiation grade: 13 cases were well-differentiated, 18 cases were moderately differentiated and 26 cases were poorly differentiated. The expression of IEX-1 in Si Ha, He La, C-33a cervical cancer cell lines was detected by Western Blot method, and the expression of IEX-1 protein in Si Ha, He La, C-33a cervical cancer cell lines was detected by Western Blot method. Statistical analysis showed that the expression of IEX-1 in normal cervical tissues, CIN tissues and cervical cancer tissues decreased in turn. The expression of IEX-1 in cervical cancer tissues was not correlated with age, pathological type and FIGO stage (all P 0.05). The expression of IEX-1 was correlated with the degree of differentiation and the depth of myometrial invasion. The lower the degree of differentiation, the lower the positive expression rate of IEX-1 protein (c 2 = 6.642, P = 0.0090.05). The positive expression rate of IEX-1 protein in deep myometrial infiltrators was significantly lower than that in superficial myometrial infiltrators only (c2 = 5.076, P = 0.0250.05). 2. Detection of IEX-1 m RNA expression in Si Ha cells, He La cells and C-33a cells by RT-q PCR showed that the expression of IEX-1 m RNA in C-33a cells (21.652 + 9.020) was higher than that in Si Ha cells (1.006 + 0.027) and He La cells (1.742 + 0.027). 854 (PSi Ha-C-33a = 0.0030.05, PHe La-C-33a = 0.0030.05). There was no significant difference in IEX-1m RNA expression between Si Ha cells and He La cells (PSi Ha-He La = 0.8680.05). 3. Western Blot assay of IEX-1 protein expression in Si Ha cells, He La cells and C-33a cells showed that IEX-1 protein expression in C-33a cells was higher than that in Si Ha cells (18.017 + 1.351). There was no significant difference in IEX-1 protein expression between Si Ha cells and He La cells (PSi Ha-C-33a 0.001, PHe La-C-33a 0.001). 4. Si Ha cells were divided into interference group, negative control group and blank control group. The interference group was transfected into E6-specific Si RNA sequence, negative pair. After transfection, the expression levels of E6 m RNA and IEX-1 m RNA in the negative control group and blank control group were detected by RT-q PCR respectively. The expression levels of E6 m RNA and IEX-1 m RNA in the interference group (0.218 +0.106) were significantly lower than those in the negative control group (1.031 +0.072) and blank control group (1.031 +0.072). There was no significant difference in the expression of E6 m RNA between the negative control group and the blank control group (P-negative control = 0.2070.05). The expression of IEX-1m RNA in the interference group (20.083 + 0.672) was significantly higher than that in the negative control group (1.613 + 0.408) and the blank control group (0.001). There was no significant difference in the expression of IEX-1 m RNA between negative control group and blank control group (P-negative control = 0.3040.05). 5. Western Blot method was used to detect the expression of E6 and IEX-1 protein in interference group, negative control group and blank control group respectively. The level of E6 protein expression in the interference group (0.184+0.274) was significantly lower than that in the negative control group (0.692+0.133) and the blank control group (0.783+0.097) (P interference-negative control 0.001, P interference-blank control 0.001), and there was no significant difference between the negative control group and the blank control group (P negative control-blank control = 0.001). 1840.05). The expression level of IEX-1 protein in the interference group (0.672.135) was significantly higher than that in the negative control group (0.137.071) and the blank control group (0.081.009) (P interference-negative control = 0.0010.05, P interference-blank control 0.001). There was no significant difference in the expression level of IEX-1 protein between the negative control group and blank control group (P negative control-blank control-blank control). Conclusion 1. The expression of IEX-1 in cervical cancer tissues decreased, and its expression level was negatively correlated with the malignant degree of cervical cancer. The decrease or deletion of IEX-1 expression in cervical epithelial cells may be involved in the occurrence and development of cervical cancer. 2. The expression level of IEX-1 in cervical cancer cells was negatively correlated with HPV infection and H infection. IEX-1 and HPV may play an opposite role in cervical carcinogenesis. 3. E6-specific Si RNA can silence the expression of E6 protein in cervical cancer cell lines. After HPV E6 silencing, the expression of IEX-1 is up-regulated, and HPV may down-regulate the expression of IEX-1 through E6 oncoprotein.
【学位授予单位】:郑州大学
【学位级别】:硕士
【学位授予年份】:2016
【分类号】:R737.33
【相似文献】
相关期刊论文 前10条
1 徐艳红;;宫颈癌的致病因素及预防的研究综述[J];中国实用医药;2009年25期
2 毕建军;杨慧兰;;单纯疱疹病毒2型与宫颈癌相关性的研究进展[J];实用医学杂志;2011年03期
3 孟斐;;组织因子途径抑制物-2在宫颈癌中表达情况的研究分析[J];中国实用医药;2013年05期
4 刘威;高文霞;;宫颈癌患者组织及血清血管内皮生长因子的变化研究[J];中国药物经济学;2013年04期
5 拉莱·苏祖克;表皮生长因子受体和转化生长因子-α在宫颈癌中的表达[J];诊断病理学杂志;2000年04期
6 许争峰,胡娅莉,王迅美,戴鲁琴,韩克,束泽宝;宫颈组织标本中端粒酶活性检测及临床意义[J];江苏医药;2001年05期
7 邹红燕,姚安梅,杨栓雀,赵西侠;青年宫颈癌相关因素分析[J];陕西肿瘤医学;2001年03期
8 张忠福,李辉;宫颈癌合并妊娠的诊断与治疗[J];中国实用妇科与产科杂志;2004年07期
9 小松;;宫颈癌已成女性杀手[J];中国医药指南;2004年03期
10 李隆玉,李诚信;宫颈癌的预防及普查[J];继续医学教育;2005年05期
相关会议论文 前10条
1 谭文福;吴绪峰;陈惠祯;;年轻宫颈癌的临床特征及防治[A];全国子宫颈癌暨湖北省妇科肿瘤专业委员会第五次妇科肿瘤学术会议论文汇编[C];2006年
2 王勒渝;;宫颈Ⅰ号栓阻断宫颈癌发生的组织病理学、超微结构及免疫组织化学的研究[A];第八届全国中西医结合肿瘤学术会议论文集[C];2000年
3 段微;;超高频无线电波刀治疗宫颈癌前病变的研究[A];2000全国肿瘤学术大会论文集[C];2000年
4 黄妙玲;陈R,
本文编号:2234997
本文链接:https://www.wllwen.com/yixuelunwen/zlx/2234997.html